Sage Therapeutics, Inc. Lease, Cost
Sage Therapeutics, Inc. reported Lease, Cost of $7.45 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-11.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:LeaseCost · last filed 2025-02-11
- Sage Therapeutics, Inc. lease, cost for fiscal 2024 was $7.45M, a 10.19% decline from fiscal 2023.
- Sage Therapeutics, Inc. lease, cost for fiscal 2023 was $8.29M, a 1.05% decline from fiscal 2022.
- Sage Therapeutics, Inc. lease, cost for fiscal 2022 was $8.38M, a 17.97% decline from fiscal 2021.
- Sage Therapeutics, Inc. lease, cost for fiscal 2021 was $10.21M, a 8.77% decline from fiscal 2020.
| Period end | Lease, Cost 12 month |
|---|---|
| 2024-12-31 | $7.45M 10-K · filed 2025-02-11 |
| 2023-12-31 | $8.29M 10-K · filed 2025-02-11 |
| 2022-12-31 | $8.38M 10-K · filed 2025-02-11 |
| 2021-12-31 | $10.21M 10-K · filed 2024-02-14 |
| 2020-12-31 | $11.20M 10-K · filed 2023-02-16 |
| 2019-12-31 | $12.92M 10-K · filed 2022-02-24 |